HCA Healthcare, Inc. (0J1R.L)
USD 339.45
(0.75%)
USD 339.45
(0.75%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 9.62 Billion USD | 5.81% |
| 2022 | 9.09 Billion USD | -7.08% |
| 2021 | 9.79 Billion USD | 33.83% |
| 2020 | 7.31 Billion USD | 0.76% |
| 2019 | 7.26 Billion USD | 9.32% |
| 2018 | 6.64 Billion USD | 8.85% |
| 2017 | 6.1 Billion USD | -2.4% |
| 2016 | 6.25 Billion USD | 4.01% |
| 2015 | 6.01 Billion USD | 7.19% |
| 2014 | 5.6 Billion USD | 16.32% |
| 2013 | 4.82 Billion USD | -0.64% |
| 2012 | 4.85 Billion USD | 5.57% |
| 2011 | 4.59 Billion USD | 3.35% |
| 2010 | 4.44 Billion USD | 10.29% |
| 2009 | 4.03 Billion USD | 49.33% |
| 2008 | 2.7 Billion USD | -14.5% |
| 2007 | 3.15 Billion USD | 2.6% |
| 2006 | 3.07 Billion USD | 20.8% |
| 2005 | 2.54 Billion USD | -6.19% |
| 2004 | 2.71 Billion USD | -7.21% |
| 2003 | 2.92 Billion USD | 41.54% |
| 2002 | 2.06 Billion USD | -10.36% |
| 2001 | 2.3 Billion USD | 64.79% |
| 2000 | 1.4 Billion USD | -36.57% |
| 1999 | 2.2 Billion USD | -10.86% |
| 1998 | 2.47 Billion USD | 41.24% |
| 1997 | 1.75 Billion USD | -44.42% |
| 1996 | 3.15 Billion USD | 34.1% |
| 1995 | 2.35 Billion USD | 55.97% |
| 1994 | 1.5 Billion USD | -43.46% |
| 1993 | 2.66 Billion USD | 4367.34% |
| 1992 | 59.7 Million USD | 126.14% |
| 1991 | 26.4 Million USD | 13.3% |
| 1990 | 23.3 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 2.41 Billion USD | -11.75% |
| 2024 Q1 | 2.56 Billion USD | -8.6% |
| 2024 Q2 | 2.73 Billion USD | 6.68% |
| 2023 Q2 | 2.29 Billion USD | -5.09% |
| 2023 Q3 | 2.11 Billion USD | -7.94% |
| 2023 Q4 | 2.8 Billion USD | 32.69% |
| 2023 FY | 9.62 Billion USD | 5.81% |
| 2023 Q1 | 2.41 Billion USD | -0.54% |
| 2022 FY | 9.09 Billion USD | -7.08% |
| 2022 Q1 | 2.21 Billion USD | -20.8% |
| 2022 Q2 | 2.3 Billion USD | 4.16% |
| 2022 Q3 | 2.15 Billion USD | -6.55% |
| 2022 Q4 | 2.42 Billion USD | 12.82% |
| 2021 Q3 | 2.47 Billion USD | -0.48% |
| 2021 Q4 | 2.79 Billion USD | 12.94% |
| 2021 FY | 9.79 Billion USD | 33.83% |
| 2021 Q1 | 2.33 Billion USD | -4.73% |
| 2021 Q2 | 2.48 Billion USD | 6.47% |
| 2020 Q4 | 2.45 Billion USD | 85.75% |
| 2020 Q1 | 1.51 Billion USD | -24.95% |
| 2020 Q2 | 1.97 Billion USD | 29.95% |
| 2020 FY | 7.31 Billion USD | 0.76% |
| 2020 Q3 | 1.31 Billion USD | -33.18% |
| 2019 Q4 | 2.02 Billion USD | 23.87% |
| 2019 Q3 | 1.63 Billion USD | -0.91% |
| 2019 Q1 | 1.91 Billion USD | -0.62% |
| 2019 FY | 7.26 Billion USD | 9.32% |
| 2019 Q2 | 1.64 Billion USD | -13.71% |
| 2018 Q1 | 1.55 Billion USD | -13.7% |
| 2018 Q4 | 1.92 Billion USD | 27.77% |
| 2018 FY | 6.64 Billion USD | 8.85% |
| 2018 Q3 | 1.5 Billion USD | -9.23% |
| 2018 Q2 | 1.65 Billion USD | 6.56% |
| 2017 FY | 6.1 Billion USD | -2.4% |
| 2017 Q1 | 1.47 Billion USD | -12.94% |
| 2017 Q2 | 1.55 Billion USD | 5.56% |
| 2017 Q3 | 1.22 Billion USD | -21.34% |
| 2017 Q4 | 1.8 Billion USD | 47.3% |
| 2016 Q3 | 1.44 Billion USD | -7.28% |
| 2016 Q1 | 1.51 Billion USD | -7.97% |
| 2016 FY | 6.25 Billion USD | 4.01% |
| 2016 Q2 | 1.55 Billion USD | 2.71% |
| 2016 Q4 | 1.69 Billion USD | 17.57% |
| 2015 Q1 | 1.46 Billion USD | -1.14% |
| 2015 Q4 | 1.64 Billion USD | 24.09% |
| 2015 Q3 | 1.32 Billion USD | -13.41% |
| 2015 FY | 6.01 Billion USD | 7.19% |
| 2015 Q2 | 1.52 Billion USD | 4.08% |
| 2014 FY | 5.6 Billion USD | 16.32% |
| 2014 Q4 | 1.48 Billion USD | 9.75% |
| 2014 Q3 | 1.35 Billion USD | -11.91% |
| 2014 Q2 | 1.53 Billion USD | 29.38% |
| 2014 Q1 | 1.18 Billion USD | -5.19% |
| 2013 Q4 | 1.25 Billion USD | 8.86% |
| 2013 Q2 | 1.25 Billion USD | 10.21% |
| 2013 FY | 4.82 Billion USD | -0.64% |
| 2013 Q1 | 1.13 Billion USD | -0.79% |
| 2013 Q3 | 1.15 Billion USD | -8.07% |
| 2012 Q2 | 1.14 Billion USD | -17.63% |
| 2012 FY | 4.85 Billion USD | 5.57% |
| 2012 Q4 | 1.14 Billion USD | 2.6% |
| 2012 Q3 | 1.11 Billion USD | -2.87% |
| 2012 Q1 | 1.39 Billion USD | 15.19% |
| 2011 Q1 | 1.15 Billion USD | 13.78% |
| 2011 FY | 4.59 Billion USD | 3.35% |
| 2011 Q4 | 1.21 Billion USD | 23.32% |
| 2011 Q3 | 982 Million USD | -0.71% |
| 2011 Q2 | 989 Million USD | -14.45% |
| 2010 Q1 | 1.15 Billion USD | 24.97% |
| 2010 Q2 | 1.06 Billion USD | -7.91% |
| 2010 Q4 | 1.01 Billion USD | 8.32% |
| 2010 Q3 | 938 Million USD | -11.51% |
| 2010 FY | 4.44 Billion USD | 10.29% |
| 2009 FY | 4.03 Billion USD | 49.33% |
| 2009 Q3 | 866 Million USD | -11.45% |
| 2009 Q4 | 921 Million USD | 6.35% |
| 2009 Q1 | 1.03 Billion USD | 24.82% |
| 2009 Q2 | 978 Million USD | -5.6% |
| 2008 Q3 | 663 Million USD | -3.35% |
| 2008 Q4 | 830 Million USD | 25.19% |
| 2008 FY | 2.7 Billion USD | -14.5% |
| 2008 Q1 | 823 Million USD | 4.05% |
| 2008 Q2 | 686 Million USD | -16.65% |
| 2007 FY | 3.15 Billion USD | 2.6% |
| 2007 Q1 | 921 Million USD | -0.97% |
| 2007 Q2 | 819 Million USD | -11.07% |
| 2007 Q3 | 627 Million USD | -23.44% |
| 2007 Q4 | 791 Million USD | 26.16% |
| 2006 Q3 | 588 Million USD | -17.42% |
| 2006 Q2 | 712 Million USD | -16.04% |
| 2006 Q1 | 848 Million USD | 26.38% |
| 2006 Q4 | 930 Million USD | 58.16% |
| 2006 FY | 3.07 Billion USD | 20.8% |
| 2005 Q2 | 754 Million USD | -13.03% |
| 2005 Q4 | 671 Million USD | 9.64% |
| 2005 FY | 2.54 Billion USD | -6.19% |
| 2005 Q3 | 612 Million USD | -18.83% |
| 2005 Q1 | 867 Million USD | 26.57% |
| 2004 FY | 2.71 Billion USD | -7.21% |
| 2004 Q1 | 732 Million USD | 10.91% |
| 2004 Q2 | 736 Million USD | 0.55% |
| 2004 Q3 | 551 Million USD | -25.14% |
| 2004 Q4 | 685 Million USD | 24.32% |
| 2003 Q3 | 659 Million USD | 17.68% |
| 2003 Q2 | 560 Million USD | -39.0% |
| 2003 Q4 | 660 Million USD | 0.15% |
| 2003 Q1 | 918 Million USD | 1539.29% |
| 2003 FY | 2.92 Billion USD | 41.54% |
| 2002 FY | 2.06 Billion USD | -10.36% |
| 2002 Q2 | 731 Million USD | -6.52% |
| 2002 Q1 | 782 Million USD | 184.36% |
| 2002 Q3 | 480 Million USD | -34.34% |
| 2002 Q4 | 56 Million USD | -88.33% |
| 2001 Q2 | 612 Million USD | -15.93% |
| 2001 FY | 2.3 Billion USD | 64.79% |
| 2001 Q1 | 728 Million USD | 158.16% |
| 2001 Q4 | 275 Million USD | -54.92% |
| 2001 Q3 | 610 Million USD | -0.33% |
| 2000 Q1 | 650 Million USD | 20.15% |
| 2000 Q4 | 282 Million USD | -41.49% |
| 2000 Q3 | 482 Million USD | 349.74% |
| 2000 Q2 | -193 Million USD | -129.69% |
| 2000 FY | 1.4 Billion USD | -36.57% |
| 1999 FY | 2.2 Billion USD | -10.86% |
| 1999 Q3 | 385 Million USD | -3.27% |
| 1999 Q4 | 541 Million USD | 40.52% |
| 1999 Q1 | 547 Million USD | 17.13% |
| 1999 Q2 | 398 Million USD | -27.24% |
| 1998 Q2 | 452 Million USD | -17.82% |
| 1998 Q4 | 467 Million USD | 31.92% |
| 1998 FY | 2.47 Billion USD | 41.24% |
| 1998 Q1 | 550 Million USD | 167.4% |
| 1998 Q3 | 354 Million USD | -21.68% |
| 1997 Q4 | -816 Million USD | -331.16% |
| 1997 FY | 1.75 Billion USD | -44.42% |
| 1997 Q3 | 353 Million USD | -57.11% |
| 1997 Q2 | 823 Million USD | -8.66% |
| 1997 Q1 | 901 Million USD | -7.87% |
| 1996 Q4 | 978 Million USD | 53.29% |
| 1996 FY | 3.15 Billion USD | 34.1% |
| 1996 Q1 | 812 Million USD | 94.72% |
| 1996 Q3 | 638 Million USD | -12.12% |
| 1996 Q2 | 726 Million USD | -10.59% |
| 1995 Q2 | 645 Million USD | 14.16% |
| 1995 Q1 | 565 Million USD | 63.77% |
| 1995 FY | 2.35 Billion USD | 55.97% |
| 1995 Q4 | 417 Million USD | -26.71% |
| 1995 Q3 | 569 Million USD | -11.78% |
| 1994 Q4 | 345 Million USD | 1.47% |
| 1994 FY | 1.5 Billion USD | -43.46% |
| 1994 Q1 | 445 Million USD | -53.11% |
| 1994 Q2 | 378 Million USD | -15.06% |
| 1994 Q3 | 340 Million USD | -10.05% |
| 1993 FY | 2.66 Billion USD | 4367.34% |
| 1993 Q1 | 17.3 Million USD | -27.62% |
| 1993 Q2 | 14.7 Million USD | -15.03% |
| 1993 Q3 | 119 Million USD | 709.52% |
| 1993 Q4 | 949 Million USD | 697.48% |
| 1992 Q4 | 23.9 Million USD | 856.0% |
| 1992 Q3 | 2.5 Million USD | -69.51% |
| 1992 Q2 | 8.2 Million USD | 28.13% |
| 1992 Q1 | 6.4 Million USD | 36.17% |
| 1992 FY | 59.7 Million USD | 126.14% |
| 1991 Q1 | 5.4 Million USD | 125.0% |
| 1991 Q2 | 5.1 Million USD | -5.56% |
| 1991 FY | 26.4 Million USD | 13.3% |
| 1991 Q3 | 4.6 Million USD | -9.8% |
| 1991 Q4 | 4.7 Million USD | 2.17% |
| 1990 Q3 | 3.4 Million USD | -38.18% |
| 1990 Q1 | 47.7 Million USD | 0.0% |
| 1990 Q2 | 5.5 Million USD | -88.47% |
| 1990 Q4 | 2.4 Million USD | -29.41% |
| 1990 FY | 23.3 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Phreesia, Inc. | -131.77 Million USD | 7405.745% |
| Accuray Incorporated | 504 Thousand USD | -1910019.048% |
| Align Technology, Inc. | 643.33 Million USD | -1396.414% |
| Elevance Health Inc. | 133.96 Billion USD | 92.814% |
| AxoGen, Inc. | -21.46 Million USD | 44956.025% |
| Boston Scientific Corporation | 2.34 Billion USD | -310.883% |
| CVS Health Corporation | 13.74 Billion USD | 29.95% |
| Cardinal Health, Inc. | 1.24 Billion USD | -674.497% |
| Centene Corporation | 2.93 Billion USD | -228.567% |
| DaVita Inc. | 1.6 Billion USD | -500.642% |
| Hologic, Inc. | 970.2 Million USD | -892.27% |
| Humana Inc. | 4.01 Billion USD | -139.895% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | -777.473% |
| Laboratory Corporation of America Holdings | 725.6 Million USD | -1226.764% |
| Masimo Corporation | 136.5 Million USD | -6952.747% |
| McKesson Corporation | 3.9 Billion USD | -146.278% |
| Patterson Companies, Inc. | 252.92 Million USD | -3706.282% |
| Quest Diagnostics Incorporated | 1.26 Billion USD | -662.837% |
| ResMed Inc. | 1.31 Billion USD | -629.377% |
| Henry Schein, Inc. | 615 Million USD | -1465.366% |
| Teladoc Health, Inc. | -248.55 Million USD | 3973.218% |
| Universal Health Services, Inc. | 1.17 Billion USD | -719.054% |
| Veeva Systems Inc. | 429.33 Million USD | -2142.31% |
| Baxter International Inc. | 390 Million USD | -2368.462% |
| Becton, Dickinson and Company | 2.11 Billion USD | -356.04% |
| Intuitive Surgical, Inc. | 1.76 Billion USD | -444.883% |
| Danaher Corporation | 5.38 Billion USD | -78.907% |
| Stryker Corporation | 3.88 Billion USD | -147.608% |
| Medtronic plc | 5.14 Billion USD | -87.15% |